P3 Health Partners Inc. (PIII) Form 10-Q — May 14, 2026
P3 Health Partners reported Q1 2026 revenue of $386.4 million, a 3.5% increase year-over-year, driven by higher capitation rates despite a 10% decline in at-risk membership. The company returned to profitability with $3.0 million in net income, aided by a $13.5 million reduction in prior period medical claims expense from a related party and a $8.8 million release of uncertain tax positions. However, the filing includes a critical going-concern warning, stating that existing cash resources of $25.5 million are insufficient to support planned operations for the next year.
Key figures
- Eps
- 0.37
- Revenue
- 386390000
- Net Income
- 3040000
- Total Debt
- 379256000
- Revenue Yoy
- 3.5%
- Cash Position
- 25500000
- At Risk Members
- 106400
- Medical Margin
- 73657000
- Adjusted Ebitda
- 25759000
- Debt Exchange Value
- 252500000
- New Preferred Offering
- 70000000
Price after filing
Close on the filing date to close N calendar days later (from $4.03). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.